| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Pegademase Bovine (Adagen) (CP.PHAR.392) - RETIRED (Medicaid and Ambetter December 1, 2021 | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Human Growth Hormone (Somapacitan, Somatropin) (CP.PCH.39) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Bremelanotide (Vyleesi) (CP.PHAR.434) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Handling Authorizations for Transportation (TX.UM.10.07) - RETIRED (Medicaid November 1, 2021 | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Mogamulizumab-kpkc (Poteligeo) (CP.PHAR.139)Â - RETIRED (Medicaid October 18, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Rituximab - Effective 11/1/2017 (CP.PHAR.260) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Naloxone (Evzio) (CP.PMN.139) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Influenza Testing | |
| Medicare CGS | Billing and Coding: MolDX: Decipher– Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk Disease (57143) | |
| Medicare CGS | Billing and Coding: MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer (57146) | |